Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy

Journal of Clinical Neuroscience

Volumn 15, Issue 5, 2008, Pages 502-506

  Ng, Wai Hoe ^a   Lim, Tchoyoson ^a,b  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Astrocytoma; Brain biopsy; Brain tumor; Glioma; MRI; Spectroscopy

Indexed keywords

LIPID;

ADULT; ARTICLE; ASTROCYTOMA; CASE REPORT; DIAGNOSTIC PROCEDURE; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGING; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SAMPLING ERROR; STEREOTACTIC BIOPSY;

ADULT; BRAIN NEOPLASMS; GLIOMA; HUMANS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; STEREOTAXIC TECHNIQUES;

EID: 41549106146     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.04.005     Document Type: Article

References (37)

1. Kelly P.J., Daumas-Duport C., Kispert D.B., et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66 (1987) 865-874
2. Schrer J.H. Cerebral astrocytomas and their derivatives. Am J Cancer 40 (1940) 159-198
3. Russell D.S., and Rubinstein L.J. Pathology of Tumors of the Nervous System. fifth ed. (1989), Williams & Wilkins, Baltimore pp.126-225
4. Likavcanova K., Dobrota D., Liptaj T., et al. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy. Gen Physiol Biophys 24 (2005) 327-335
5. Moon R.B., and Richards J.H. Determination of intracellular pH by 31P magnetic resonance. J Biol Chem 248 (1973) 7276-7278
6. Preul M.C., Caramanos Z., Collins D.L., et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2 (1996) 323-325
7. Cheng L.L., Burns M.A., Taylor J.L., et al. Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res 65 (2005) 3030-3034
8. Swindle P., McCredie S., Russell P., et al. Pathologic characterization of human prostate tissue with proton MR spectroscopy. Radiology 228 (2003) 144-151
9. Beloueche-Babari M., Jackson L.E., Al-Saffar N.M., et al. Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition. Cancer Res 65 (2005) 3356-3363
10. Gluch L. Magnetic resonance in surgical oncology II: literature review. ANZ J Surg 75 (2005) 464-470
11. Mahon M.M., Cox I.J., Dina R., et al. (1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load. J Magn Reson Imaging 19 (2004) 356-364
12. Cho S.G., Lee D.H., Lee K.Y., et al. Differentiation of chronic focal pancreatitis from pancreatic carcinoma by in vivo proton magnetic resonance spectroscopy. J Comput Assist Tomogr 29 (2005) 163-169
13. Khan S.A., Cox I.J., Thillainayagam A.V., et al. Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. Eur J Gastroenterol Hepatol 17 (2005) 733-738
14. Doran S.T., Falk G.L., Somorjai R.L., et al. Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy. Am J Surg 185 (2003) 232-238
15. Stevens T.K. Magnetic resonance spectroscopic techniques for localizing epileptogenic zones in refractory partial epilepsy. Adv Neurol 97 (2006) 285-292
16. den Heijer T., Sijens P.E., Prins N.D., et al. MR spectroscopy of brain white matter in the prediction of dementia. Neurology 66 (2006) 540-544
17. Mihara M., Hattori N., Abe K., et al. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex. Neuroreport 17 (2006) 413-416
18. Napoli S.Q., and Bakshi R. Magnetic resonance imaging in multiple sclerosis. Rev Neurol Dis 2 (2005) 109-116
19. Narayana P.A. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging 15 Suppl (2004) 46S-57S
20. Tartaglia M.C., and Arnold D.L. The role of MRS and fMRI in multiple sclerosis. Adv Neurol 98 (2006) 185-202
21. Fountas K.N., Kapsalaki E.Z., Gotsis S.D., et al. In vivo proton magnetic resonance spectroscopy of brain tumors. Stereotact Funct Neurosurg 74 (2000) 83-94
22. Harada M., Tanouchi M., Nishitani H., et al. Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy. Jpn J Cancer Res 86 (1995) 329-332
23. McBride D.Q., Miller B.L., Nikas D.L., et al. Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 44 (1995) 137-144
24. Kano H., Houkin K., Harada K., et al. Neuronal cell injury in patients after cardiopulmonary resuscitation: evaluation by diffusion-weighted imaging and magnetic resonance spectroscopy. Neurosurg Rev 29 (2006) 88-92
25. Tamiya T., Kinoshita K., Ono Y., et al. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 42 (2000) 333-338
26. Parmar H., Lim T.C., Yin H., et al. Multi-voxel MR spectroscopic imaging of the brain: utility in clinical setting-initial results. Eur J Radiol 55 (2005) 401-408
27. Pirzkall A., McKnight T.R., Graves E.E., et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50 (2001) 915-928
28. Lacroix M., Abi-Said D., Fourney D.R., et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95 (2001) 190-198
29. Sawaya R. Extent of resection in malignant gliomas: a critical summary. J Neurooncol 42 (1999) 303-305
30. Aker F.V., Hakan T., Karadereler S., et al. Accuracy and diagnostic yield of stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimens. Neuropathology 25 (2005) 207-213
31. Brainard J.A., Prayson R.A., and Barnett G.H. Frozen section evaluation of stereotactic brain biopsies: diagnostic yield at the stereotactic target position in 188 cases. Arch Pathol Lab Med 121 (1997) 481-484
32. DeAngelis L.M. Brain tumors. N Engl J Med 344 (2001) 114-123
33. Jung V., Romeike B.F., Henn W., et al. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J Neuropathol Exp Neurol 58 (1999) 993-999
34. Magalhaues A., Godfrey W., Shen Y., et al. Proton and magnetic resonance spectroscopy of brain tumors correlated with pathology. Acad Radiol 12 (2005) 51-57
35. Veena AN, Ye JR, Xu MS, et al. Multivoxel MR spectroscopic imaging - distinguishing intracranial tumors from non-neoplastic disease. Ann Acad Med Singapore 2007;36:In press.
36. Ishimaru H., Morikawa M., Iwanaga S., et al. Differentiation between high-grade glioma and metastatic brain tumor using single voxel proton MR spectroscopy. Eur Radiol 11 (2001) 1784-1791
37. Lim CC, Ye JR, Xu MS, et al. MR spectroscopy in brain neoplasms: Lipid signal. Ann Acad Med Singapore 2007;36:In press.